Dr. Sadiq is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
425 W 59th St
Suite 7C
New York, NY 10019Phone+1 212-523-8070Fax+1 212-523-8194
Education & Training
University of Texas Medical Branch HospitalsResidency, Neurology, 1985 - 1988
University of Nairobi College of Health SciencesClass of 1979
Certifications & Licensure
NY State Medical License 1994 - 2026
TX State Medical License 1988 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
- New York Magazine: Top Doctors Castle Connolly, 2013-2014
- Top Doctors: New York Metro Area Castle Connolly, 2011-2014
Clinical Trials
- Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis Start of enrollment: 2014 Apr 01
- Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis Start of enrollment: 2018 Sep 21
- Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis
Publications & Presentations
PubMed
- Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulator.Tyler P Molitor, Genki Hayashi, Mei-Yao Lin, Carissa J Dunn, Nathan G Peterson
Proceedings of the National Academy of Sciences of the United States of America. 2025-04-01 - 3 citationsEfficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial.Violaine K Harris, James Stark, Armistead Williams, Morgan Roche, Michaela Malin
Stem Cell Research & Therapy. 2024-05-23 - 6 citationsCerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic.Jamie K Wong, Jerry Lin, Nathan J Kung, Alexandra L Tse, Serena J E Shimshak
Brain. 2023-05-02
Press Mentions
Studies on MS Diets, Stem Cells and Health Disparities Are Among Those Reported at the AAN MeetingMay 3rd, 2023- New Hope for Potential MS TreatmentApril 21st, 2023
- New Study Shows How Primary Progressive MS May Differ from Other Forms of MSFebruary 9th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
